Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity

Area of Science:

• Immunology
• Pharmacology
• Clinical Medicine

Background:

• Phenytoin is an anticonvulsant medication.
• Hypersensitivity reactions to phenytoin can occur.
• Immunodeficiency is a potential adverse effect.

Observation:

• A patient developed rash, lymphadenopathy, and elevated transaminases after starting phenytoin.
• Subsequent panhypogammaglobulinemia with severely reduced IgG, IgA, and IgM levels was observed.
• Normal T-cell immunity contrasted with a marked deficiency in B-lymphocytes and immunoglobulin production.

Findings:

• Phenytoin therapy led to a significant decrease in circulating B-lymphocytes and immunoglobulin production.
• In vitro lymphocyte analysis confirmed normal T-cell function but impaired B-cell function.
• The observed immunodeficiency persisted for at least three years after phenytoin withdrawal.

Implications:

• This case highlights a rare but severe B-cell immunodeficiency induced by phenytoin.
• The findings suggest a potential for long-lasting immune system impairment following phenytoin-induced hypersensitivity.
• Further investigation into the mechanisms of phenytoin-induced B-cell lymphopenia is warranted.